ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma
Article in Pathology - Research and Practice (March 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in Pathology - Research and Practice (March 2024)
Article in Frontiers in Cell and Developmental Biology (January 2024)
Article in Digestive Diseases and Sciences (January 2024)